Lv2
140 积分 2026-02-25 加入
Palbociclib for Hormone-Receptor–Positive, HER2-Positive Advanced Breast Cancer
4个月前
已完结
From bench to bedside: Synthetic strategies and clinical application of PARP inhibitors
5个月前
已完结
Targeting selective inhibitors of PARPs in drug discovery and development
5个月前
已完结
The Discovery of a Potent PARP1 Inhibitor Senaparib
5个月前
已完结